Every patient has the right to live without pain. The law protects and guarantees patients’ access to pain treatment and palliative care, with respect for human dignity and individual autonomy.
The calling of a physician is to empathetically accompany patients through illness, resulting in a tailored treatment plan unique to each patient, where alleviating unnecessary suffering is an essential component. The quality of pain management care reflects the level of humanism within a society.
Molteni’s work in pain management is extensive. It encompasses a comprehensive portfolio that includes opioid medications for pain treatment, such as fentanyl (featuring PecSys technology for breakthrough pain), oxycodone (widely used in postoperative analgesia), morphine (also approved for pediatric use), and methadone (the only one available on the market). Additionally, Molteni offers the latest medications aimed at minimizing the side effects associated with opioid use, such as opioid-induced bowel dysfunction (OIBD) and opioid-induced constipation (OIC). Molteni introduced Rizmoic to Poland, the only oral PAMORA (peripherally acting μ-opioid receptor antagonist) available on the Polish market.
